A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

por Jackson, AG, Kløverpris, HN, Handley, A, Hayes, P, Gilmour, J, Atkins, M, Walker, B, Ackland, J, Sullivan, M, Goulder, P
Publicado 2012